
Olsavas H 12.5mg/40mg Tablet
Marketer
Orchid Chemicals & Pharmaceuticals Ltd
Salt Composition
Hydrochlorothiazide (12.5mg) + Olmesartan Medoxomil (40mg)
Overview Olsavas H 12.5mg/40mg Tablet
Hypertensive patients may benefit from the dual-action formulation, Olsavas H 12.5 mg/40 mg Tablet. This medication manages hypertension through a combined approach. Untreated hypertension significantly elevates the risk of serious complications such as stroke, myocardial infarction, and renal failure. Olsavas H can be ingested with or without food; dosage is individualized based on patient response and condition, ideally at the same time daily for consistent efficacy. Continuous use, as directed by your physician, is crucial. The formulation includes a diuretic, potentially increasing urination frequency; therefore, avoid administration within four hours of bedtime. Regular intake maximizes therapeutic benefits, even during asymptomatic periods, as hypertension often presents subtly. Discontinuation increases cardiovascular event risk. Commonly reported side effects include dizziness, fatigue, cephalgia, and myalgia. Chest discomfort and fluid retention are also possible. Increased urination is expected due to the diuretic component and is not considered an adverse effect. While rare, other side effects may occur. Elevated intraocular pressure, potentially causing irreversible vision impairment if untreated, is a noted, though infrequent, possibility. Consult the accompanying patient information leaflet and inform your healthcare provider of any persistent or bothersome adverse events. Dosage adjustments or alternative therapies may be considered. The medication is contraindicated during pregnancy and lactation; prior consultation with your physician is mandatory if you have pre-existing hepatic or renal dysfunction, cardiac conditions, or diabetes. Alcohol consumption should be limited due to its potential to exacerbate hypotensive effects.
Primary Ingredients of Olsavas H 12.5mg/40mg Tablet
No text provided to rephrase.
Uses of Olsavas H 12.5mg/40mg Tablet
Elevated blood pressure
Major Benefits of Olsavas H 12.5mg/40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Olsavas H 12.5 mg/40 mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Olsavas H 12.5mg/40mg Tablet:
- Dizziness
- Weakness
- Tiredness
- Edema (swelling)
- Chest pain
- Upper respiratory tract infection
- Headache
- Increased triglyceride level in blood
- Increased uric acid level in blood
- Abdominal pain
- Back pain
- Skeletal pain
- Blood in urine
- Increased liver enzymes
- Increased blood urea
How to use Olsavas H 12.5mg/40mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olsavas H 12.5 mg/40 mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Olsavas H 12.5mg/40mg Tablet works:
Each Olsavas H tablet (12.5 mg/40 mg) contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olsavas H 12.5 mg/40 mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Olsavas H 12.5 mg/40 mg tablets is contraindicated during pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Olsavas H 12.5 mg/40 mg tablets without significant risk to their infants. Available human data indicate minimal danger to the baby.
DrivingUNSAFE
Taking Olsavas H 12.5 mg/40 mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olsavas H 12.5 mg/40 mg tablets. Dosage modification might be necessary; physician consultation is recommended. Routine blood pressure checks are advised to guide dosage adjustments.
LiverCAUTION
Patients with liver impairment should exercise caution when using Olsavas H 12.5 mg/40 mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Olsavas H 12.5mg/40mg Tablet :
Should you forget to take a dose of Olsavas H 12.5 mg/40 mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olsavas H 12.5mg/40mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
